Literature DB >> 15039347

Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model.

Rosemary Santangelo1, Hans Zoellner, Tania Sorrell, Christabel Wilson, Christine Donald, Julianne Djordjevic, Yi Shounan, Lesley Wright.   

Abstract

Secreted phospholipase B (PLB) activity promotes the survival and replication of Cryptococcus neoformans in macrophages in vitro. We therefore investigated the role of mononuclear phagocytes and cryptococcal PLB in the dissemination of infection in a mouse model, using C. neoformans var. grubii wild-type strain H99, a PLB1 deletion mutant (Delta plb1), and a reconstituted strain (Delta plb1(rec)). PLB facilitated the entry of endotracheally administered cryptococci into lung IM. PLB was also required for lymphatic spread from the lung to regional lymph nodes and for entry into the blood. Langhans-type giant cells containing budding cryptococci were seen free in the lymphatic sinuses of hilar nodes of H99- and Delta plb1(rec)-infected mice, suggesting that they may have a role in the dissemination of cryptococcal infection. The transfer of infected lung macrophages to recipient mice by tail vein injections demonstrated that these cells can facilitate hematogenous dissemination of cryptococci to the brain, independent of cryptococcal PLB secretion. PLB activities of cryptococci isolated from lung macrophages or infected brains were not persistently increased. We conclude that mononuclear phagocytes are a vehicle for cryptococcal dissemination and that PLB activity is necessary for the initiation of interstitial pulmonary infections and for dissemination from the lung via the lymphatics and blood. PLB is not, however, essential for the establishment of neurological infections when cryptococci are presented within, or after passage through, mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039347      PMCID: PMC375158          DOI: 10.1128/IAI.72.4.2229-2239.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state.

Authors:  Rosemary T Santangelo; M Hossein Nouri-Sorkhabi; Tania C Sorrell; Michelle Cagney; Sharon C A Chen; Philip W Kuchel; Lesley C Wright
Journal:  J Med Microbiol       Date:  1999-08       Impact factor: 2.472

Review 2.  Cells and cytokines in pulmonary cryptococcosis.

Authors:  G B Huffnagle; M F Lipscomb
Journal:  Res Immunol       Date:  1998 May-Jun

3.  Metabolites released by Cryptococcus neoformans var. neoformans and var. gattii differentially affect human neutrophil function.

Authors:  Lesley Wright; William Bubb; John Davidson; Rosemary Santangelo; Mark Krockenberger; Uwe Himmelreich; Tania Sorrell
Journal:  Microbes Infect       Date:  2002-11       Impact factor: 2.700

4.  The origins, kinetics, and fate of macrophage populations.

Authors:  B Roser
Journal:  J Reticuloendothel Soc       Date:  1970-08

5.  Strain-dependent effects of environmental signals on the production of extracellular phospholipase by Cryptococcus neoformans.

Authors:  Lesley C Wright; Sharon C A Chen; Christabel F Wilson; Mukoma F Simpanya; Rebecca Blackstock; Gary M Cox; Juneann W Murphy; Tania C Sorrell
Journal:  FEMS Microbiol Lett       Date:  2002-04-09       Impact factor: 2.742

Review 6.  Intracellular parasitism of macrophages by Cryptococcus neoformans.

Authors:  M Feldmesser; S Tucker; A Casadevall
Journal:  Trends Microbiol       Date:  2001-06       Impact factor: 17.079

7.  Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans.

Authors:  G M Cox; H C McDade; S C Chen; S C Tucker; M Gottfredsson; L C Wright; T C Sorrell; S D Leidich; A Casadevall; M A Ghannoum; J R Perfect
Journal:  Mol Microbiol       Date:  2001-01       Impact factor: 3.501

8.  Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production.

Authors:  Mairi C Noverr; Gary M Cox; John R Perfect; Gary B Huffnagle
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

9.  Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis.

Authors:  Wu He; Arturo Casadevall; Sunhee C Lee; David L Goldman
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

10.  Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia.

Authors:  Fabrice Chrétien; Olivier Lortholary; Imad Kansau; Ségolène Neuville; Françoise Gray; Françoise Dromer
Journal:  J Infect Dis       Date:  2002-08-02       Impact factor: 5.226

View more
  74 in total

1.  In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans.

Authors:  Ranjini Ganendren; Fred Widmer; Vatsala Singhal; Christabel Wilson; Tania Sorrell; Lesley Wright
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  Fungal pathogen recognition by scavenger receptors in nematodes and mammals.

Authors:  Terry K Means
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

3.  Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection.

Authors:  Kirsten Nielsen; Gary M Cox; Anastasia P Litvintseva; Eleftherios Mylonakis; Stephanie D Malliaris; Daniel K Benjamin; Steven S Giles; Thomas G Mitchell; Arturo Casadevall; John R Perfect; Joseph Heitman
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.

Authors:  David O Beenhouwer; Esther M Yoo; Chun-Wei Lai; Miguel A Rocha; Sherie L Morrison
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

5.  Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis.

Authors:  Fred Widmer; Lesley C Wright; Daniel Obando; Rosemary Handke; Ranjini Ganendren; David H Ellis; Tania C Sorrell
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

6.  Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans.

Authors:  Kerstin Voelz; David A Lammas; Robin C May
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

7.  Using C. elegans for antimicrobial drug discovery.

Authors:  Athanasios Desalermos; Maged Muhammed; Justin Glavis-Bloom; Eleftherios Mylonakis
Journal:  Expert Opin Drug Discov       Date:  2011-06-01       Impact factor: 6.098

8.  New insights on the pathogenesis of invasive Cryptococcus neoformans infection.

Authors:  Helene C Eisenman; Arturo Casadevall; Erin E McClelland
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

9.  Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier.

Authors:  Yun C Chang; Monique F Stins; Michael J McCaffery; Georgina F Miller; Dan R Pare; Tapen Dam; Maneesh Paul-Satyaseela; Kwang Sik Kim; Kyung J Kwon-Chung; Maneesh Paul-Satyasee
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Cryptococcal cell morphology affects host cell interactions and pathogenicity.

Authors:  Laura H Okagaki; Anna K Strain; Judith N Nielsen; Caroline Charlier; Nicholas J Baltes; Fabrice Chrétien; Joseph Heitman; Françoise Dromer; Kirsten Nielsen
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.